These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 19361594)
21. [Procedural success and 10-month outcome between Cypher and TAXUS drug-eluting stents for the treatment of in-stent restenosis]. Chen JL; Yang YJ; Qiao SB; Yao M; Qin XW; Xu B; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Li JJ; Gao RL Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Apr; 35(4):305-7. PubMed ID: 17711652 [TBL] [Abstract][Full Text] [Related]
22. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. Weissman NJ; Koglin J; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Kutcher M; Wong SC; Strickland W; Mooney M; Russell ME; Ellis SG; Stone GW J Am Coll Cardiol; 2005 Apr; 45(8):1201-5. PubMed ID: 15837249 [TBL] [Abstract][Full Text] [Related]
23. Randomized comparison of the Nobori Biolimus A9-eluting coronary stent with the Taxus Liberté paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2. Chevalier B; Silber S; Park SJ; Garcia E; Schuler G; Suryapranata H; Koolen J; Hauptmann KE; Wijns W; Morice MC; Carrie D; van Es GA; Nagai H; Detiege D; Paunovic D; Serruys PW; Circ Cardiovasc Interv; 2009 Jun; 2(3):188-95. PubMed ID: 20031715 [TBL] [Abstract][Full Text] [Related]
25. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Colombo A; Orlic D; Stankovic G; Corvaja N; Spanos V; Montorfano M; Liistro F; Carlino M; Airoldi F; Chieffo A; Di Mario C Circulation; 2003 May; 107(17):2178-80. PubMed ID: 12719283 [TBL] [Abstract][Full Text] [Related]
26. Stent malapposition after sirolimus-eluting and bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: acute and 9-month intravascular ultrasound results of the MISSION! intervention study. van der Hoeven BL; Liem SS; Dijkstra J; Bergheanu SC; Putter H; Antoni ML; Atsma DE; Bootsma M; Zeppenfeld K; Jukema JW; Schalij MJ JACC Cardiovasc Interv; 2008 Apr; 1(2):192-201. PubMed ID: 19463300 [TBL] [Abstract][Full Text] [Related]
27. Serial greyscale and radiofrequency intravascular ultrasound assessment of plaque modification and vessel geometry at proximal and distal edges of bare metal and first-generation drug-eluting stents. Ribamar Costa J; Abizaid A; Sousa A; Siqueira D; Chamié D; Feres F; Costa R; Staico R; Maldonado G; Centemero M; Tanajura LF; Viana R; Chaves Á; Abizaid A; Sousa JE EuroIntervention; 2012 Jun; 8(2):225-34. PubMed ID: 22717925 [TBL] [Abstract][Full Text] [Related]
28. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. Waseda K; Miyazawa A; Ako J; Hasegawa T; Tsujino I; Sakurai R; Yock PG; Honda Y; Kandzari DE; Leon MB; Fitzgerald PJ; JACC Cardiovasc Interv; 2009 Aug; 2(8):779-84. PubMed ID: 19695548 [TBL] [Abstract][Full Text] [Related]
29. Comparison of inflammatory response after implantation of sirolimus- and paclitaxel-eluting stents in porcine coronary arteries. Wilson GJ; Nakazawa G; Schwartz RS; Huibregtse B; Poff B; Herbst TJ; Baim DS; Virmani R Circulation; 2009 Jul; 120(2):141-9, 1-2. PubMed ID: 19564562 [TBL] [Abstract][Full Text] [Related]
30. Late vascular response at the edges of sirolimus analogous-eluting stents in diabetic patients: An intravascular ultrasound study. Lasave LI; Abizaid AA; de Ribamar Costa J; Tanajura LF; Feres F; Abizaid AS; Siqueira D; Staico R; Sousa AG; Sousa JE Catheter Cardiovasc Interv; 2007 Oct; 70(4):498-503. PubMed ID: 17503511 [TBL] [Abstract][Full Text] [Related]
31. Peri-stent reference segment plaque burden is associated with disease progression in saphenous vein grafts (a serial intravascular ultrasound assessment). Hong YJ; Mintz GS; Kim SW; Okabe T; Lu L; Bui AB; Pichard AD; Satler LF; Waksman R; Kent KM; Suddath WO; Weissman NJ Am J Cardiol; 2007 Oct; 100(8):1233-8. PubMed ID: 17920363 [TBL] [Abstract][Full Text] [Related]
32. Differences in restenosis rate with different drug-eluting stents in patients with and without diabetes mellitus: a report from the SCAAR (Swedish Angiography and Angioplasty Registry). Fröbert O; Lagerqvist B; Carlsson J; Lindbäck J; Stenestrand U; James SK J Am Coll Cardiol; 2009 May; 53(18):1660-7. PubMed ID: 19406341 [TBL] [Abstract][Full Text] [Related]
33. Outcome of undersized drug-eluting stents for percutaneous coronary intervention of saphenous vein graft lesions. Hong YJ; Pichard AD; Mintz GS; Kim SW; Lee SY; Kim SY; Ahn Y; Jeong MH; Satler LF; Kent KM; Suddath WO; Weissman NJ; Kang JC; Waksman R Am J Cardiol; 2010 Jan; 105(2):179-85. PubMed ID: 20102915 [TBL] [Abstract][Full Text] [Related]
34. Effect of plaque volume on subsequent vessel remodeling at edges of sirolimus-eluting stents. Asano T; Kobayashi Y; Mintz GS; Ishio N; Fujimaki S; Ogawa Y; Nakayama T; Kuroda N; Komuro I Am J Cardiol; 2006 Oct; 98(8):1041-4. PubMed ID: 17027567 [TBL] [Abstract][Full Text] [Related]
35. Usual dose of simvastatin does not inhibit plaque progression and lumen loss at the peri-stent reference segments after bare-metal stent implantation: a serial intravascular ultrasound analysis. Hong YJ; Jeong MH; Choi YH; Ma EH; Ko JS; Lee MG; Park KH; Sim DS; Yoon NS; Youn HJ; Kim KH; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC Korean J Intern Med; 2010 Dec; 25(4):356-63. PubMed ID: 21179272 [TBL] [Abstract][Full Text] [Related]
36. Serial intravascular ultrasound assessment of very late stent thrombosis after sirolimus-eluting stent placement. Yamanaga K; Tsujita K; Shimomura H; Nakamura Y; Ogura Y; Onoue Y; Chazono N; Nagata T; Morisaki S; Kudo T; Yamada Y; Komura N; Miyazaki T; Akasaka T; Horio E; Sato K; Arima Y; Kojima S; Kaikita K; Tayama S; Hokimoto S; Ogawa H J Cardiol; 2014 Oct; 64(4):279-84. PubMed ID: 24674747 [TBL] [Abstract][Full Text] [Related]
37. Characterization of edge effects with paclitaxel-eluting stents using serial intravascular ultrasound radiofrequency data analysis: the BETAX (BEside TAXus) Study. García-García HM; Gonzalo N; Tanimoto S; Meliga E; de Jaegere P; Serruys PW Rev Esp Cardiol; 2008 Oct; 61(10):1013-9. PubMed ID: 18817677 [TBL] [Abstract][Full Text] [Related]
38. Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: a volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials. Weissman NJ; Ellis SG; Grube E; Dawkins KD; Greenberg JD; Mann T; Cannon LA; Cambier PA; Fernandez S; Mintz GS; Mandinov L; Koglin J; Stone GW Eur Heart J; 2007 Jul; 28(13):1574-82. PubMed ID: 17540849 [TBL] [Abstract][Full Text] [Related]
39. [Intravascular ultrasonic evaluation of poststenting atherosclerotic plaque redistribution and lumen reduction at the stent edge: does stent length matter?]. Wang XF; Lu CZ; Xia DS Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jun; 36(6):481-4. PubMed ID: 19100055 [TBL] [Abstract][Full Text] [Related]
40. [Comparison of different drug-eluting stents in the treatment of coronary artery disease: a single center four-year clinical follow-up]. Gao LJ; Chen JL; Chen J; Gao RL; Yang YJ; Xu B; Qin XW; Qiao SB; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J Zhonghua Nei Ke Za Zhi; 2008 Jul; 47(7):541-4. PubMed ID: 19035161 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]